A pilot study to assess clinical safety and tolerance of minocycline and spinal perfusion pressure augmentation in acute spinal cord injury
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Minocycline (Primary)
- Indications Spinal cord injuries
- Focus Adverse reactions; Therapeutic Use
- 18 Mar 2013 Biomarkers information updated
- 27 Nov 2007 New trial record.